Red sun pharmaceutical: some directors and executives have reduced their holdings of 2330000 shares through block trading
Cailian, September 7 (Reuters) - HongRi pharmaceutical announced that the company received a notice from Zheng Dan and LAN Wujun, directors of the company, and Chen Ruiqiang, Zhang Kun and Li Chunxu, deputy general managers of the company today. The above personnel reduced a total of 2330000 shares of the company through the block trading system of Shenzhen Stock Exchange on September 6, 2021, accounting for 0.0776% of the total share capital of the company.
This text is a result of machine translation.
Related companies：
Briefing Jun 01, 2022 09:23 AM
· Financials
American officials: the United States plans to expand its diplomatic presence in the Indian Pacific Region
In-depth
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Briefing Feb 28, 2022 07:19 PM
· Financials
Ant insurance online "golden selection" service
In-depth
Briefing Feb 11, 2022 11:29 AM
· Financials
Insurance stocks continued to strengthen, with China life up more than 7%
See more
Read next
Insight
In-depth
Consumer Discretionary · Analysis
Black Friday Kicks Off: How to Navigate the Latin American Market?
Nov 20, 2024 10:36 AM
Insight
In-depth
Consumer Staples, Consumer Discretionary · Interview
Exploring Uncharted Territories in the Middle East: The Innovators Going Global
Nov 19, 2024 03:20 PM
Insight
In-depth
Insight
In-depth
Consumer Staples
The Billion-Dollar European Caviar Business, Now Disrupted by China
Nov 08, 2024 01:52 PM